Holder snapshot 7 signals
Share change
-142,091
Put/Call ratio
356%
SEC-reported price per share
$19.21
Indexed holders
90
Value change
-$7,907,090
Number of buys
54
Open additional details 1 more signal available
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
123,305,030

Security key

N62509109

Report period

Q2 2024

Indexed institutions

90

Top holders

10

Ownership snapshot

Top reported holders of NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR 0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F Highest disclosed value: $294,690,878 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Frazier Life Sciences Management, L.P. has the largest disclosed position value at $294.69M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Frazier Life Sciences Management,... $294.69M
FCPM III SERVICES B.V. $279.81M
Bain Capital Life Sciences Invest... $248.81M
VIKING GLOBAL INVESTORS LP $189.78M
RA CAPITAL MANAGEMENT, L.P. $189.66M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Frazier Life Sciences Management, L.P.
13F
Company
13F
—
mixed-class rows
$294,690,878
12,727,276 shares
mixed-class rows
— 31 Mar 2024
FCPM III SERVICES B.V.
13F
Company
13F
—
denominator unverified
$279,814,053
11,831,461 shares
— 31 Mar 2024
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
mixed-class rows
$248,812,042
10,573,913 shares
mixed-class rows
— 31 Mar 2024
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$189,780,962
8,024,565 shares
— 31 Mar 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
mixed-class rows
$189,663,596
8,197,333 shares
mixed-class rows
— 31 Mar 2024
Medicxi Ventures Management (Jersey) Ltd
13F
Company
13F
—
denominator unverified
$67,865,212
2,869,565 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
90
Shares
72,010,250
Indexed holders
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 indexed holders
76
Q2 2024 indexed holders
90
Indexed holder difference
14
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .